Haloperidol Wzf (Haloperidol)

Haloperidol Wzf is prescribed for the management of several acute and chronic psychiatric disorders.

• Schizophrenia, including maintenance therapy and relapse prevention.
• Acute psychotic episodes associated with bipolar disorder or other conditions.
• Manic episodes in bipolar I disorder.
• Tourette syndrome, particularly when other treatments are insufficient.
• Severe agitation or aggression in a hospital setting.

Side effects of haloperidol may vary in frequency and severity.

Common

• Drowsiness or sedation.
• Extrapyramidal symptoms such as tremor, rigidity, or akathisia.
• Dry mouth.
• Constipation.
• Blurred vision.

Serious

• Neuroleptic malignant syndrome.
• Tardive dyskinesia.
• Severe hypotension.
• Cardiac arrhythmias, including QT prolongation.

When prescribing Haloperidol Wzf, clinicians consider several safety precautions to minimize risk.

• Assess cardiovascular status, especially for QT prolongation risk.
• Monitor for signs of extrapyramidal reactions and adjust dose accordingly.
• Use caution in patients with a history of seizures or neuroleptic malignant syndrome.
• Evaluate liver and renal function before initiating therapy.
• Consider pregnancy and lactation status; use only if benefits outweigh potential risks.
• Review patient’s age, as elderly individuals may be more sensitive to side effects.

Haloperidol can interact with other medications, affecting its efficacy or safety profile.

Avoid

• Other dopamine antagonists or antipsychotics (increased risk of additive side effects).
• Medications that prolong QT interval (e.g., certain antiarrhythmics, macrolide antibiotics).
• Strong CYP3A4 inhibitors such as ketoconazole (may increase haloperidol levels).

Use with caution

• CYP3A4 inducers like carbamazepine (may reduce effectiveness).
• CNS depressants including benzodiazepines or alcohol (enhanced sedation).
• Anticholinergic agents (may mask extrapyramidal symptoms).